|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 9
Zeitschriftenartikel
Scheubeck, Gabriel 
ORCID: https://orcid.org/0009-0004-2546-6154; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Hermine, Olivier; Kluin-Nelemans, Hanneke C.; Schmidt, Christian; Unterhalt, Michael; Rosenwald, Andreas; Klapper, Wolfram ORCID: https://orcid.org/0000-0001-7208-4117; Evangelista, Andrea; Ladetto, Marco; Jerkeman, Mats ORCID: https://orcid.org/0000-0003-4509-6707; Ferrero, Simone ORCID: https://orcid.org/0000-0002-9711-1502; Dreyling, Martin und Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389
(2023):
Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression).
In: Leukemia, Bd. 37, Nr. 9: S. 1887-1894
[PDF, 1MB]
ORCID: https://orcid.org/0009-0004-2546-6154; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Hermine, Olivier; Kluin-Nelemans, Hanneke C.; Schmidt, Christian; Unterhalt, Michael; Rosenwald, Andreas; Klapper, Wolfram ORCID: https://orcid.org/0000-0001-7208-4117; Evangelista, Andrea; Ladetto, Marco; Jerkeman, Mats ORCID: https://orcid.org/0000-0003-4509-6707; Ferrero, Simone ORCID: https://orcid.org/0000-0002-9711-1502; Dreyling, Martin und Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389
(2023):
Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression).
In: Leukemia, Bd. 37, Nr. 9: S. 1887-1894
[PDF, 1MB]
Dreyling, Martin; Andre, Marc; Gökbuget, Nicola; Tilly, Herve; Jerkeman, Mats; Gribben, John; Ferreri, Andres; Morel, Pierre; Stilgenbauer, Stephan; Fox, Christopher; Ribera, Jose Maria; Zweegman, Sonja; Aurer, Igor; Bödür, Csaba; Burkhardt, Birgit; Buske, Christian; Caballero, MariaDollores; Campo, Elias; Chapuy, Björn; Davies, Andrew; Leval, Laurence de; Doorduijn, Jeanette; Federico, Massimo; Gaulard, Philippe; Gay, Francesca; Ghia, Paolo; Gronbaek, Kirsten; Goldschmidt, Hartmut; Kersten, Marie-Jose; Kiesewetter, Barbara; Landman-Parker, Judith; Le Gouill, Steven; Lenz, Georg; Leppä, Sirpa; Lopez-Guillermo, Armando; Macintyre, Elizabeth; Mateos Mantega, Maria Victoria; Moreau, Philippe; Moreno, Carol; Nadel, Bertrand; Okosun, Jessica; Owen, Roger; Pospisilova, Sarka; Pott, Christiane; Robak, Tadeusz; Spina, Michelle; Stamatopoulos, Kostas; Stary, Jan; Tarte, Karin; Tedeschi, Allessandra; Thieblemont, Catherine; Trappe, Ralf Ulrich; Trümper, Lorenz H. und Salles, Gilles
(2022):
The EHA Research Roadmap: Malignant Lymphoid Diseases.
In: Hemasphere, Bd. 6, Nr. 6
[PDF, 2MB]
Wang, Michael L.; Jurczak, Wojciech; Jerkeman, Mats; Trotman, Judith; Zinzani, Pier L.; Belada, David; Boccomini, Carola; Flinn, Ian W.; Giri, Pratyush; Goy, Andre; Hamlin, Paul A.; Hermine, Olivier; Hernandez-Rivas, Jose-Angel; Hong, Xiaonan; Kim, Seok Jin; Lewis, David; Mishima, Yuko; Ozcan, Muhit; Perini, Guilherme F.; Pocock, Christopher; Song, Yuqin; Spurgeon, Stephen E.; Storring, John M.; Walewski, Jan; Zhu, Jun; Qin, Rui; Henninger, Todd; Deshpande, Sanjay; Howes, Angela; Le Gouill, Steven und Dreyling, Martin
(2022):
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma.
In: New England Journal of Medicine, Bd. 386, Nr. 26: S. 2482-2494
Horgan, Denis; Walewski, Jan; Aurer, Igor; Visco, Carlo; Gine, Eva; Fetica, Bogdan; Jerkeman, Mats; Kozaric, Marta; da Silva, Maria Gomes und Dreyling, Martin
(2022):
Tackling Mantle Cell Lymphoma in Europe.
In: Healthcare, Bd. 10, Nr. 9, 1682
Dreyling, Martin; Aurer, Igor; Federico, Massimo; Jerkeman, Mats; Kersten, Marie Jose; Linton, Kim; Mey, Ulrich; Tilly, Herve und Buske, Christian
(2021):
EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 Pandemic.
In: Hemasphere, Bd. 5, Nr. 2, e529
Morello, Lucia; Rattotti, Sara; Giordano, Laura; Jerkeman, Mats; Meerten, Tom van; Krawczyk, Katarzyna; Moita, Filipa; Marino, Dario; Ferrero, Simone; Szymczyk, Michal; Aurer, Igor; El-Galaly, Tarec Christoffer; Di Rocco, Alice; Visco, Carlo; Carli, Giuseppe; Defrancesco, Irene; Carlo-Stella, Carmelo; Dreyling, Martin; Santoro, Armando und Arcaini, Luca
(2020):
Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study.
In: Hemasphere, Bd. 4, Nr. 1, e302
Dreyling, Martin; Aurer, Igor; Cortelazzo, Sergio; Hermine, Olivier; Hess, Georg; Jerkeman, Mats; Le Gouill, Steven; Ribrag, Vincent; Trneny, Marek; Visco, Carlo; Walewski, Jan; Zaja, Francesco und Zinzani, Pier Luigi
(2018):
Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations.
In: Leukemia & Lymphoma, Bd. 59, Nr. 8: S. 1814-1828
Hess, Georg; Rule, Simon; Jurczak, Wojciech; Jerkeman, Mats; Silva, Rodrigo Santucci; Rusconi, Chiara; Caballero, Dolores; Joao, Cristina; Witzens-Harig, Mathias; Bence-Bruckler, Isabelle; Cho, Seok-Goo; Zhou, Wenjiong; Goldberg, Jenna D.; Trambitas, Cristina; Enny, Christopher; Vermeulen, Jessica; Traina, Shana; Chiou, Chiun-Fang; Diels, Joris und Dreyling, Martin
(2017):
Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus.
In: Leukemia & Lymphoma, Bd. 58, Nr. 12: S. 2824-2832
Dreyling, Martin; Jurczak, Wojciech; Jerkeman, Mats; Santucci Silva, Rodrigo; Rusconi, Chiara; Trneny, Marek; Offner, Fritz; Caballero, Dolores; Joao, Cristina; Witzens-Harig, Mathias; Hess, Georg; Bence-Bruckler, Isabelle; Cho, Seok-Goo; Bothos, John; Goldberg, Jenna D.; Enny, Christopher; Traina, Shana; Balasubramanian, Sriram; Bandyopadhyay, Nibedita; Sun, Steven; Vermeulen, Jessica; Rizo, Aleksandra und Rule, Simon
(2016):
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase study.
In: Lancet, Bd. 387, Nr. 10020: S. 770-778